Sudarshan Pharma Industries Share Price
10 Sep, 2026 4:01 PM (IST)
Sudarshan Pharma Industries Performance
- Today's Low
- ₹39
- Today's High
- ₹40
- 52 Week Low
- ₹19
- 52 Week High
- ₹43
- Open Price₹40
- Previous Close₹40
- Volume24,000
- 50 DMA₹38.10
- 100 DMA₹36.00
- 200 DMA₹33.20
Sudarshan Pharma Industries Chart
Investment Returns
- Over 1 Month + 22.2%
- Over 3 Month + 12.77%
- Over 6 Month + 52.87%
- Over 1 Year + 22.88%
Smart Investing Starts Here Start SIP with Sudarshan Pharma Industries for Steady Growth!
Sudarshan Pharma Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 40.8
- PEG Ratio
- 2.5
- Market Cap Cr
- 950
- P/B Ratio
- 5.9
- Average True Range
- 2
- EPS
- 1
- Dividend Yield
- 0
- MACD Signal
- 0.8
- RSI
- 52.69
- MFI
- 80.86
Latest Stock News Updates
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta
- BSE India
- 1 day 12 hours ago
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal Vasantrai Mehta
- BSE India
- 1 day 12 hours ago
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directros have at their Meeting held today, 05/Sept/2026, inter alia, approved to acquire 24,23,675.64 equity shares of the common stock, of MedTherapy Biotechnology Inc, USA, incorporated under the laws of the State of Delaware, equivalent to 9.50% of the issued and outstanding share capital of the Company. Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company shall acquire 3,82,685.63 equity shares each of common stock, equivalent to 1.50% each of the issued and outstanding equity share capital of the Company. Additional details in the letter attached herewith.
- BSE India
- 5 days 13 hours ago
Sudarshan Pharma Industries Financials
Sudarshan Pharma Industries Technicals
EMA & SMA
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹39.20
- 50 Day
- ₹38.10
- 100 Day
- ₹36.00
- 200 Day
- ₹33.20
Resistance and Support
- R3 40.40
- R2 40.20
- R1 39.80
- S1 39.30
- S2 39.10
- S3 38.70
Sudarshan Pharma Industries Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-06-18 | Issue Of Warrants | Inter-alia, to consider 1. Proposal for raising of funds by way of issue of one or more instruments through private placement / preferential issue or such method or combination thereof |
| 2026-05-21 | Others | (Revised) Inter-alia to consider 1. Approve Migration of listing / trading of the Equity Shares. 2. Approve Postal Ballot Notice & Calendat of events for seekirg approval. 3. Other business matters. |
| 2026-05-15 | Others | Inter-alia, to consider 1. The proposal for the issuance of Foreign Currency Convertible Bonds, subject to receipt of applicable regulatory and statutory approvals. |
| 2026-04-30 | Audited Results |
About Sudarshan Pharma Industries
Sudarshan Pharma Industries engaged in manufacturing having plant for API and doing jobwork manufacturing in Pharmeceutical Items and traders in Chemicals and Solvents in India. View More- NSE Symbol
- SUDARSHAN
- BSE Symbol
- 543828
- ISIN
- INE00TV01023
Similar Stocks to Sudarshan Pharma Industries
Popular Stocks
Sudarshan Pharma Industries FAQs
Sudarshan Pharma Industries share price is ₹39 As on 11 September, 2026 | 08:36
The Market Cap of Sudarshan Pharma Industries is ₹949.9 Cr As on 11 September, 2026 | 08:36
The P/E ratio of Sudarshan Pharma Industries is 40.8 As on 11 September, 2026 | 08:36
The PB ratio of Sudarshan Pharma Industries is 5.9 As on 11 September, 2026 | 08:36
The 52 week High & Low of Sudarshan Pharma Industries is ₹42.8/₹18.5 respectively As on 11 September, 2026 | 08:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.